BLLN Stock Analysis: Buy, Sell, or Hold?
$95.03
-0.24 (-0.25%)
▼
5d:
+1.82%
30d:
-26.3%
90d:
+10.31%
HOLD
LOW Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Aug 05, 2026
0d
Get Alerted When BLLN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: BLLN shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: BLLN shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$32.93
Based on -0.2% avg growth
INTRINSIC VALUE TODAY
$20.45
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: BLLN is currently trading at $95.03, which is considered oversold relative to its 30-day fair value range of $96.48 to $136.55. From a valuation perspective, the stock is trading at a discount (Forward PE: 71.5) compared to its historical average (122.1). Remarkably, the market is currently pricing in an annual earnings decline of 16.4% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, BLLN is in a strong uptrend. Immediate support is located at $87.96, while resistance sits at $99.53.
Market Sentiment: BLLN scores 93/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $119.71 (+26.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, BLLN is in a strong uptrend. Immediate support is located at $87.96, while resistance sits at $99.53.
Market Sentiment: BLLN scores 93/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $119.71 (+26.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$96.48 -
$136.55
Company Quality Score
68/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
92.3%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Options cheap (IV 0th percentile)
- BULLISH: Strong technical setup (93/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 26.0% below Wall St target ($119.71)
- CAUTION: Bottoming setup, but lagging the sector by 24% over 20 days — wait for relative strength
Trading Range Analysis
30-Day Trading Range
$96.48 -
$136.55
Current vs Trading Range
OVERSOLD
Expected Move (7 Days)
±$7.81
(8.2%)
Support & Resistance Levels
Support Level
$87.96
Resistance Level
$99.53
Current Trend
Strong Uptrend
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
71.45
Wall Street Target
$119.71
(+26.0%)
Revenue Growth (YoY)
64.4%
Profit Margin
8.3%
Valuation Discount vs History
-16.4% cheaper
PE vs Historical
71.5 vs 122.1
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-16.4%
(market-implied from PE analysis)
1-Year Target
$85.53
(-10%)
2-Year Target
$76.97
(-19%)
3-Year Target
$69.28
(-27%)
3-Yr Target (if PE normalizes)
(PE: 71→122)
$118.38
(+25%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 71.5, Growth: -4.3%)
$83.25
(+-12%)
Base:
(SPY PE: 20.1, Growth: -4.3%)
$23.38
(-75%)
Bear:
(PE: 17.1, Growth: -4.3%)
$19.88
(-79%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (129x PE), but valuation improves significantly next year (71x PE) as earnings recover.
Trailing PE: 128.74 | Current EPS (TTM): $0.74
Bull Case
$188.35
(+98%)
Analyst growth 79.7%, PE expands to 141.6
Base Case
$171.23
(+80%)
Market implied 79.7%, PE stable at 128.7
Bear Case
$64.78
(-32%)
Severe decline -20.0%, PE contracts to 109.4
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 71.5 to 122.1
Stabilization Target:
$162.39
(+70.9%)
PE Expansion Potential:
+70.9%
Share & Embed Analysis
Last updated: August 23, 2026 9:05 AM ET
Data refreshes hourly during market hours. Next update: 10:05 AM
Data refreshes hourly during market hours. Next update: 10:05 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BLLN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$631 | 41 HOLD |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 52 HOLD |
|
GH
Guardant Health Inc |
STRONG BUY
23 analysts |
$194 | 50 HOLD |
|
DHR
Danaher Corporation |
STRONG BUY
25 analysts |
$228 | 43 HOLD |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$337 | 38 SELL |